Amgen Science - Biotechnology for the Next Decade

(2:41)

Amgen Science 2020 Year-In-Review

(2:20)

Fast Facts about Biological Drugs - Amgen Science

(48)

Introduction to the Amgen Biotech Experience (ABE) - Amgen Science

(2:47)

How Amgen is using Generative Biology and AI

(2:31)

The Hunt for New Checkpoint Inhibitors - Amgen Science

(5:24)

Fast Facts about Biosimilars - Amgen Science

(43)

Fast Facts About the Quality of Biosimilars – Amgen Science

(1:28)

ʻOumuamua: Our First Interstellar Visitor | How the Universe Works | Science Channel

(8:44)

The Challenges in Manufacturing Biologics

(5:9)

Biotechnology and Healthcare: A New Dawn? CEO Bob Bradway on Money Maze Podcast

(35:47)

Introduction to Bone Biology

(2:44)

Dr. Ryan Potts, Ph.D. - VP and Head, Induced Proximity Platform, Amgen - Any Target, Every Time

(58:34)

Deshaies (Amgen) 2: Cullin-RING ubiquitin ligases: structure, mechanism, and regulation

(40:35)

Welcome to Amgen Dún Laoghaire ADL - Biologic Medicine Manufacturing

(3:47)

Low Carb is Winning with Dr. Joel Kahn

(29:54)

Innovation Squared: Ep 6 | Synchronicity, A Catalyst

(17:55)

Deshaies (Amgen) 1: A primer on the ubiquitin-proteasome system

(35:8)

Mycena and allied genera - how to know the Mycenoid fungi

(1:31:19)

The Answers Within - Biology First

(2:9)

Fast Facts About Efficacy of Biosimilars – Amgen Science

(1:8)

We Are the Amgen Biotech Experience (ABE)

(2:11)

Fast Facts about Extrapolation for Biosimilars - Amgen Science

(51)

Protein Engineering: Unlocking the Power of Proteins | Amgen Science

(1:45)

Biotechnology by Amgen: Using Innovation to Advance Medicine

(2:)

Biosimilars - pushing the boundaries of science to transform medicine - Amgen

(4:37)

Online Science Education Platform - LabXchange from Amgen and Harvard

(1:34)

Fast Facts About the Regulatory Approval Pathway for Biosimilars – Amgen Science

(1:44)

Amgen Oncology: See Life Break Through

(3:46)